How much funding has Centrexion Therapeutics raised?

Centrexion Therapeutics has raised $192.4M in total funding, most recently a Venture Round.

Who are Centrexion Therapeutics's investors?

Centrexion Therapeutics's investors include NEA, Fidelity Management, Eli Lilly, Exome Asset Management.

When was Centrexion Therapeutics founded?

Centrexion Therapeutics was founded in 2013.

Where is Centrexion Therapeutics headquartered?

Centrexion Therapeutics is headquartered in Boston, Massachusetts, United States.

How many employees does Centrexion Therapeutics have?

Centrexion Therapeutics has 11-50 employees.

Centrexion Therapeutics

Q: What industry is Centrexion Therapeutics in?

Centrexion Therapeutics operates in Biopharmaceutical, CNS, Pain Management, Biotech, Drug Discovery, Healthcare, Therapeutics.

Boston, United States · Founded 2013 · $192.4M raised

Biopharmaceutical

CNS

Pain Management

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: centrexion.com
Total Funding: $192.4M
Last Round: $10.3M Venture RoundJun 2023
Rounds: 6

About

Centrexion Therapeutics is a clinical-stage biopharmaceutical company developing a broad pipeline of novel, non-opioid, non-addictive therapies for chronic pain and immunology. Its mechanism-driven approach spans topical, injectable, and oral modalities, with partnerships with Lilly, Boehringer Ingelheim, Sanofi, and NIH validating its scientific platform. The company aims to be the premier pain therapeutics powerhouse by addressing safety and efficacy gaps in current treatments.

Summary

Centrexion Therapeutics is a Biopharmaceutical company based in Boston, United States, founded in 2013. It has raised $192.4M in total across 6 rounds, most recently a $10.3M Venture Round round in Jun 2023. Investors include NEA, Fidelity Management and Eli Lilly.

LinkedIn X (Twitter)